Cytosorbents Crp Cash Flow-to-Debt Ratio
Cytosorbents Crp cash flow-to-debt ratio. Cytosorbents Crp (CTSO) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2026, meaning its operating cash flow of $-1.75 Million could theoretically repay 0% of its total liabilities ($38.71 Million) in one year. Check Cytosorbents Crp cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cytosorbents Crp (2004–2025)
Cash flow-to-debt ratio of Cytosorbents Crp from 2004 to 2025. Historical debt coverage capacity for Cytosorbents Crp across 22 annual periods. Check Cytosorbents Crp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Cytosorbents Crp Cash Flow-to-Debt Ratio by Year (2004–2025)
Cytosorbents Crp cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for Cytosorbents Crp. For the full cash flow conversion analysis, see CTSO cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.32x | $-12.38 Million | $38.28 Million | ▲ +18.7% |
| 2024 | -0.40x | $-14.43 Million | $36.26 Million | ▲ +44.9% |
| 2023 | -0.72x | $-21.66 Million | $29.99 Million | ▲ +28.7% |
| 2022 | -1.01x | $-28.23 Million | $27.86 Million | ▼ -95.0% |
| 2021 | -0.52x | $-14.01 Million | $26.94 Million | ▲ +0.6% |
| 2020 | -0.52x | $-5.61 Million | $10.73 Million | ▲ +25.2% |
| 2019 | -0.70x | $-16.76 Million | $23.96 Million | ▼ -2.0% |
| 2018 | -0.69x | $-10.84 Million | $15.81 Million | ▼ -46.9% |
| 2017 | -0.47x | $-6.46 Million | $13.84 Million | ▲ +29.5% |
| 2016 | -0.66x | $-6.73 Million | $10.17 Million | ▲ +77.6% |
| 2015 | -2.96x | $-9.01 Million | $3.04 Million | ▼ -100.2% |
| 2014 | -1.48x | $-6.66 Million | $4.51 Million | ▼ -675.8% |
| 2013 | -0.19x | $-3.49 Million | $18.31 Million | ▲ +21.1% |
| 2012 | -0.24x | $-3.62 Million | $14.96 Million | ▲ +88.6% |
| 2011 | -2.12x | $-3.83 Million | $1.80 Million | ▼ -96.7% |
| 2010 | -1.08x | $-2.48 Million | $2.30 Million | ▲ +60.8% |
| 2009 | -2.76x | $-2.67 Million | $970.76K | ▼ -19.7% |
| 2008 | -2.30x | $-2.37 Million | $1.03 Million | ▲ +20.6% |
| 2007 | -2.90x | $-2.63 Million | $906.87K | ▼ -10.0% |
| 2006 | -2.63x | $-2.85 Million | $1.08 Million | ▼ -437.0% |
| 2005 | -0.49x | $-50.00K | $101.97K | ▲ +11.7% |
| 2004 | -0.56x | $-50.00K | $90.00K | — |